Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Breast Cancer Res Treat
; 188(1): 77-89, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-33728524
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Everolimus
Limits:
Female
/
Humans
Country/Region as subject:
Asia
Language:
En
Year:
2021
Type:
Article